Nigeria’s pharmaceutical companies are ramping up investments and expanding operations to tap growing local opportunities.

Report on how AI is driving market transformation- The global menstrual drugs market size is estimated to grow by US ...

GSK, formerly known as GlaxoSmithKline ... Sanofi specializes in prescription medicines, vaccines and consumer health care products, focusing on areas such as cardiovascular disease, diabetes ...

GSK and other pharma companies that have sold ranitidine products over the years have ... which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and ...

Some of the world’s largest pharmaceutical companies - faced with looming patent expirations on some of their best-selling prescription ... drug development work. GSK shareholders are certainly ...

B2B pharma covers the sale of prescription drugs and medicines that ... The importance of the corporate brand that links these products is often forgotten. That brand is more than just a logo ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Nevertheless, Haleon is a great stock for the current environment we’re in. The resilience of its brands is fueling investors’ interest in HLN — as are fears about a slowing U.S. economy and ...

Read on to learn how GSK ... prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and ...

Haleon (HLN): A spin-out from GSK, Haleon produces consumer, non-prescription healthcare products in oral health, supplements ...

Buyout firm GTCR is in advanced talks on a potential acquisition of German generic drugmaker Stada Arzneimittel AG, people ...